Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Magnesium Glycinate | Potassium (Citrate) | |
|---|---|---|
| Category | Minerals | Minerals |
| Standard Dose | 200-400mg elemental magnesium daily | 99-200mg per capsule (regulatory limit in US); dietary target 3500-4700mg/day total |
| Timing | Evening/bedtime (promotes relaxation and sleep quality). Can split AM/PM. | With meals, divided throughout the day. Slow-release forms preferred for higher doses. |
| Cycle Duration | ongoing | ongoing |
| Evidence Level | strong_human | strong_human |
Magnesium is a cofactor for >600 enzymatic reactions including all ATP-dependent reactions (Mg-ATP is the true substrate), DNA/RNA polymerases, and ion channel regulation. Magnesium glycinate chelate provides highly bioavailable elemental magnesium bound to glycine. The glycine moiety itself is an inhibitory neurotransmitter (glycine receptors) and NMDA receptor co-agonist at the glycine binding site. The chelated form minimizes the osmotic laxative effect of ionic magnesium salts. Magnesium regulates NMDA receptor gating (voltage-dependent Mg2+ block), GABA-A receptor potentiation, HPA axis modulation, and parathyroid hormone secretion.
200-400mg elemental magnesium daily
Evening/bedtime (promotes relaxation and sleep quality). Can split AM/PM.
ongoing
Potassium is the principal intracellular cation, maintaining resting membrane potential (-70 to -90mV) via the Na+/K+-ATPase pump (3 Na+ out, 2 K+ in per ATP). It is essential for: cardiac rhythmicity (phase 3 repolarization of cardiac action potential), skeletal muscle contraction, nerve impulse transmission, acid-base balance (exchanged for H+ in renal tubules), blood pressure regulation (promotes natriuresis via renal sodium excretion), and insulin secretion. Citrate form provides alkalinizing anion that inhibits calcium oxalate and uric acid kidney stone formation.
99-200mg per capsule (regulatory limit in US); dietary target 3500-4700mg/day total
With meals, divided throughout the day. Slow-release forms preferred for higher doses.
ongoing
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →